查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2030 年製藥隔離器市場預測：按類型、系統類型、壓力、配置、配銷通路、應用、最終用戶和地區進行的全球分析
市場調查報告書
商品編碼
1383483

2030 年製藥隔離器市場預測：按類型、系統類型、壓力、配置、配銷通路、應用、最終用戶和地區進行的全球分析

Pharmaceutical Isolator Market Forecasts to 2030 - Global Analysis By Type, System Type, Pressure, Configuration, Distribution Channel, Application, End User and by Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球藥物隔離器市場規模為 124.5 億美元，預計 2030 年將達到 248.2 億美元，預測期內年複合成長率為 10.36%。

藥物隔離器用作屏障系統以防止污染。藥物隔離器用於多種行業，包括微生物測試、細胞治療加工、先進藥物製造 (ATMP) 以及無菌注射劑計量、包裝和分銷。

根據美國藥物研究和工業2021 年 9 月更新的資料，自 2000 年以來，PhRMA 成員公司已花費超過 1.1 兆美元尋找新的治療方法和治療方法。光是 2021 年我們就投資了 1,023 億美元。

對藥理學無菌操作的需求不斷增加

人們越來越認知到清潔度在藥品製造中發揮的關鍵作用，這推動了對無菌製劑製程的需求。製藥公司努力提供最好的藥物，使隔離器成為必不可少的設備。此外，我們透過最先進的密封和空氣過濾系統仔細監控環境，確保我們的藥品保持純淨和完好無損。

預算限制和前期投資

藥物隔離器具有許多優點，包括法規遵循和污染控制，但其安裝需要初期成本。然而，一些製藥公司可能會發現很難為隔離系統的設計、安裝和檢驗提供資金，特別是當它們規模較小或資金有限時。儘管隔離器能帶來長期好處，但這種財務障礙可能會阻礙普及。

隔離器技術開發

隨著隔離器技術的不斷進步，製藥公司擁有許多機會。有助於隔離器解決方案開發的創新包括更好的密封系統、改進的材料設計和更易於使用的介面。此外，投資於研發的隔離器技術領域的公司可以透過解決現有問題並提供滿足不斷變化的市場需求的尖端解決方案來受益於競爭優勢。

替代遏制技術的興起

藥物隔離器在市場上的主導地位受到密封技術動態環境中替代解決方案的出現的威脅。根據應用的不同，先進的屏障技術、機器人系統或封閉系統處理替代方案可能是吸引人們對傳統隔離器解決方案的關注和資金的可行選擇。此外，隔離器製造商必須不斷創新並突顯其產品的獨特價值提案，以減輕此威脅。

COVID-19 的影響：

藥物隔離器市場受到了 COVID-19大流行的各種影響。由於大流行，對藥物開發和醫療保健的日益關注推動了對藥物隔離器的需求，但也受到勞動力短缺、全球供應鏈中斷和不確定的經濟狀況的阻礙。此外，疫情凸顯了靈活敏捷的製造流程的重要性，促使公司重新評估和改進其遏制計劃。這可能會刺激大流行後藥物隔離器市場的創新。

預計落地式細分市場在預測期內將是最大的

由於其寬敞的工作空間和針對不同製造流程的彈性，落地式細分市場在藥物隔離器市場中佔據最大佔有率。落地式隔離器為複雜任務提供了更多空間，可容納更大的設備並支援符合人體工學的工作流程。此外，由於其高度通用性，它適用於廣泛的應用，例如高藥理活性藥物的生產和無菌加工。複雜的控制系統、材料通過系統和整合式手套口只是這些隔離器經常採用的一些先進功能。

合約研究組織部門預計在預測期內複合年複合成長率最高。

合約市場研究組織（CRO）是複合年複合成長率最高的細分市場。 CRO 對於生物技術和製藥行業至關重要，因為它們為研究和開發提供專業服務。外包藥物開發和臨床試驗的趨勢正在推動對先進實驗室設備的需求，包括尖端的診斷工具和設備。此外，CRO 利用學術機構、研究中心和診斷實驗室進行廣泛的研究，加速最尖端科技的採用。

佔比最大的地區：

由於其強大的醫療保健系統、高研發支出和嚴格的法規要求，北美目前佔據藥物隔離器市場的最大佔有率。該地區營運的大量受託研究機構以及製藥和生物技術公司對隔離系統的需求產生了重大影響。此外，我們積極主動地實施最尖端科技，以及我們對維持產品品質和安全最高標準的承諾，正在推動藥物隔離器在北美的普及。

複合年複合成長率最高的地區：

由於生物技術和製藥行業的市場開拓活躍，亞太地區的市場年複合成長率最高。該地區正在增加對醫療基礎設施的投資、更加重視研發以及藥物開發活動的激增。此外，由於患者人數眾多、醫療成本上升和支持性法律規範多種因素，藥物隔離器市場正在成長。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章 執行摘要

第2章 前言

  • 概述
  • 利害關係人
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章 市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章 全球藥物隔離器市場：按類型

  • 無菌隔離器
  • 安全殼隔離裝置
  • 生物隔離器
  • 採樣和計量隔離器
  • 用於生產活性藥物原料藥(API) 的隔離器
  • 放射性藥物隔離器
  • 液體分配隔離器
  • 生產隔離器
  • 其他類型

第6章 全球藥物隔離器市場：依系統類型

  • 封閉系統
  • 開放系統

第7章 全球藥物隔離器市場：壓力

  • 正壓
  • 負壓

第8章 全球藥物隔離器市場：依構成

  • 放置樓層
  • 模組化的
  • 智慧型手機
  • 袖珍的
  • 桌上
  • 攜帶的
  • 其他配置

第9章 全球藥物隔離器市場：依配銷通路

  • 直接競標
  • 零售
  • 第三方經銷商

第10章 全球藥物隔離器市場：依應用分類

  • 無菌測試
  • 取樣/稱重/交付
  • 醫療設備製造
  • 其他用途

第11章全球藥物隔離器市場：依最終用戶分類

  • 醫院
  • 診斷實驗室
  • 學術研究所
  • 製藥和生物技術公司
  • 合約研究組織
  • 其他最終用戶

第12章全球藥物隔離器市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第13章進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第14章公司簡介

  • Getinge AB
  • Fedegari Autoclavi SpA
  • Azbil Corporation
  • Schematic Engineering Industries
  • Germfree Laboratories, Inc.
  • Chiyoda Corporation
  • Hosokawa Micron BV
  • Bioquell Inc.
  • NuAire Inc
  • Hecht Technologie Gmbh
  • Comecer SPA
  • Skan AG
  • M. Braun Inertgas-Systeme Gmbh
  • Tema Sinergie SPA
  • Chamunda Pharma Machinery Pvt. Ltd
  • Isotech Design
Product Code: SMRC24331

According to Stratistics MRC, the Global Pharmaceutical Isolator Market is accounted for $12.45 billion in 2023 and is expected to reach $24.82 billion by 2030 growing at a CAGR of 10.36% during the forecast period. Pharmaceutical isolators are employed as a barrier system that prevents contamination. Pharmaceutical isolators are used in a variety of industries, including microbiological testing, cell therapy processing, advanced pharmaceutical manufacturing (ATMP) and the weighing, packaging, and distribution of sterile injectable products.

According to the Pharmaceutical Research and Manufacturers of America data updates from September 2021, since 2000, PhRMA member companies have invested more than USD 1.1 Trillion in the search for new treatments and cures, including USD 102.3 Billion in 2021 alone.

Market Dynamics:

Driver:

Growing requirement for pharmacological sterile procedures

The increasing recognition of the vital role cleanliness plays in the production of pharmaceuticals is driving the demand for sterile pharmaceutical processes. Isolators become essential instruments as pharmaceutical companies work to provide the best possible drugs. Moreover, pharmaceutical products are kept pure and undamaged thanks to these carefully monitored settings that are outfitted with cutting-edge containment and air filtration systems.

Restraint:

Budgetary restrictions and upfront investment

Pharmaceutical isolators have many advantages, such as regulatory compliance and contamination control, but their installation is expensive up front. However, some pharmaceutical companies may find it difficult to afford the costs involved in designing, installing, and validating isolator systems, particularly smaller ones or those with more restricted funding. Despite the long-term benefits that isolators offer, this financial barrier may prevent widespread adoption.

Opportunity:

Technological developments in isolators

Pharmaceutical companies have a lot of potential thanks to ongoing advancements in isolator technology. Innovations that contribute to the development of isolator solutions include better containment systems, improved material designs, and more user-friendly interfaces. Moreover, businesses in the isolator technology sector that make research and development investments stand to benefit from a competitive advantage by providing cutting-edge solutions that solve existing issues and fit the changing demands of the market.

Threat:

Rising alternative technologies for containment

The dominant position of pharmaceutical isolators in the market is under threat from the emergence of alternative solutions in the dynamic landscape of containment technologies. For some applications, advanced barrier technologies, robotic systems, or alternatives to closed-system processing may be viable options that draw attention and funding away from conventional isolator solutions. Additionally, manufacturers of isolators must constantly innovate and highlight the distinctive value proposition of their goods in order to lessen this threat.

COVID-19 Impact:

The pharmaceutical isolator market has been impacted by the COVID-19 pandemic in many ways. The demand for pharmaceutical isolators has been fueled by the pandemic's increased focus on drug development and healthcare, but there have been obstacles due to workforce shortages, global supply chain disruptions, and uncertain economic conditions. Furthermore, the pandemic has highlighted the significance of flexible and agile manufacturing processes, leading businesses to reevaluate and improve their containment plans. This could spur innovation in the pharmaceutical isolator market in the aftermath of the pandemic.

The Floor standing segment is expected to be the largest during the forecast period

Due to its prominence in offering ample workspace and flexibility for a variety of manufacturing processes, the floor-standing segment holds the largest share of the pharmaceutical isolator market. With room for larger equipment and the ability to support ergonomic workflows, floor-standing isolators provide large spaces for intricate operations. Moreover, these are appropriate for a wide range of applications, including high-potency drug manufacturing and aseptic processing, due to their versatility. Complex control systems, material pass-through systems, and integrated glove ports are just a few examples of the advanced features that these isolators frequently incorporate.

The Contract Research Organizations segment is expected to have the highest CAGR during the forecast period

Contract Research Organizations (CROs) are the market segment with the highest CAGR. CROs are essential to the biotechnology and pharmaceutical industries because they offer specialized services for research and development. The need for sophisticated laboratory equipment, including cutting-edge diagnostic tools and instruments, has increased due to the trend of outsourcing drug development and clinical trials. Furthermore, CROs use academic institutions, research centers, and diagnostic labs to carry out extensive studies that promote the uptake of cutting-edge technologies.

Region with largest share:

Due to its strong healthcare system, large R&D expenditures, and strict regulatory requirements, North America presently commands the largest share of the market for pharmaceutical isolators. The numerous contract research organizations and the pharmaceutical and biotechnology companies that operate in the area have a significant impact on the demand for isolator systems. Moreover, a proactive approach to implementing state-of-the-art technologies and a strong focus on upholding the highest standards of product quality and safety add to the prevalence of pharmaceutical isolators in North America.

Region with highest CAGR:

The Asia-Pacific-Pacific has the highest CAGR in the market, driven by dynamic developments in the biotechnology and pharmaceutical industries. Increased investments in healthcare infrastructure, a growing focus on research and development, and a surge in drug development activities are all occurring in the region. Additionally, the market for pharmaceutical isolators is growing due to a number of factors, including a large patient population, rising healthcare costs, and a supportive regulatory framework.

Key players in the market

Some of the key players in Pharmaceutical Isolator market include: Getinge AB, Fedegari Autoclavi S.p.A, Azbil Corporation, Schematic Engineering Industries, Germfree Laboratories, Inc., Chiyoda Corporation, Hosokawa Micron B.V, Bioquell Inc., NuAire Inc, Hecht Technologie Gmbh, Comecer S.P.A, Skan AG, M. Braun Inertgas-Systeme Gmbh, Tema Sinergie S.P.A, Chamunda Pharma Machinery Pvt. Ltd and Isotech Design.

Key Developments:

In October 2023, Azbil Corporation has announced an investment agreement with Forest Energy Inc., headquartered in Tokyo. To support the realization of a sustainable society powered by renewable energy, Azbil is underwriting Forest Energy's third-party allocation of Renewable Energynew shares.

In October 2023, Germfree Laboratories and Title21 Health Solutions unveil a groundbreaking mobile manufacturing platform seamlessly integrated with an advanced manufacturing operating system, set to redefine decentralized point-of-care (POC) cell and gene therapy production. This partnership focuses on decentralized manufacturing, an innovative approach to traditional centralized models, aiming to overcome bottlenecks and streamline access to therapy delivery.

In May 2023, Getinge announces an agreement to acquire 100% of the shares in High Purity New England, Inc. a leading US-based company in the fast-growing areas of custom single-use solutions for bioprocessing applications. This acquisition is another step in Getinge Life Science strategic journey to further expand our presence in the biopharma segment, says Eric Honroth, President Life Science at Getinge.

Types Covered:

  • Aseptic Isolators
  • Containment Isolators
  • Bio Isolators
  • Sampling And Weighing Isolators
  • Active Pharmaceutical Ingredient (API) Manufacturing Isolators
  • Radiopharmaceutical Isolators
  • Fluid Dispensing Isolators
  • Production Isolators
  • Other Types

System Types Covered:

  • Closed System
  • Open System

Pressures Covered:

  • Positive Pressure
  • Negative Pressure

Configurations Covered:

  • Floor Standing
  • Modular
  • Mobile
  • Compact
  • Table Top
  • Portable
  • Other Configuartions

Distribution Channels Covered:

  • Direct Tender
  • Retail Sales
  • Third Party Distributors

Applications Covered:

  • Sterility Testing
  • Sampling/ Weighing/ Distribution
  • Medical Device Manufacturing
  • Other Applications

End Users Covered:

  • Hospitals
  • Diagnostic Laboratories
  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Pharmaceutical Isolator Market, By Type

  • 5.1 Introduction
  • 5.2 Aseptic Isolators
  • 5.3 Containment Isolators
  • 5.4 Bio Isolators
  • 5.5 Sampling And Weighing Isolators
  • 5.6 Active Pharmaceutical Ingredient (API) Manufacturing Isolators
  • 5.7 Radiopharmaceutical Isolators
  • 5.8 Fluid Dispensing Isolators
  • 5.9 Production Isolators
  • 5.10 Other Types

6 Global Pharmaceutical Isolator Market, By System Type

  • 6.1 Introduction
  • 6.2 Closed System
  • 6.3 Open System

7 Global Pharmaceutical Isolator Market, By Pressure

  • 7.1 Introduction
  • 7.2 Positive Pressure
  • 7.3 Negative Pressure

8 Global Pharmaceutical Isolator Market, By Configuration

  • 8.1 Introduction
  • 8.2 Floor Standing
  • 8.3 Modular
  • 8.4 Mobile
  • 8.5 Compact
  • 8.6 Table Top
  • 8.7 Portable
  • 8.8 Other Configuartions

9 Global Pharmaceutical Isolator Market, By Distribution Channel

  • 9.1 Introduction
  • 9.2 Direct Tender
  • 9.3 Retail Sales
  • 9.4 Third Party Distributors

10 Global Pharmaceutical Isolator Market, By Application

  • 10.1 Introduction
  • 10.2 Sterility Testing
  • 10.3 Sampling/ Weighing/ Distribution
  • 10.4 Medical Device Manufacturing
  • 10.5 Other Applications

11 Global Pharmaceutical Isolator Market, By End User

  • 11.1 Introduction
  • 11.2 Hospitals
  • 11.3 Diagnostic Laboratories
  • 11.4 Academic and Research Institutes
  • 11.5 Pharmaceutical and Biotechnology Companies
  • 11.6 Contract Research Organizations
  • 11.7 Other End Users

12 Global Pharmaceutical Isolator Market, By Geography

  • 12.1 Introduction
  • 12.2 North America
    • 12.2.1 US
    • 12.2.2 Canada
    • 12.2.3 Mexico
  • 12.3 Europe
    • 12.3.1 Germany
    • 12.3.2 UK
    • 12.3.3 Italy
    • 12.3.4 France
    • 12.3.5 Spain
    • 12.3.6 Rest of Europe
  • 12.4 Asia Pacific
    • 12.4.1 Japan
    • 12.4.2 China
    • 12.4.3 India
    • 12.4.4 Australia
    • 12.4.5 New Zealand
    • 12.4.6 South Korea
    • 12.4.7 Rest of Asia Pacific
  • 12.5 South America
    • 12.5.1 Argentina
    • 12.5.2 Brazil
    • 12.5.3 Chile
    • 12.5.4 Rest of South America
  • 12.6 Middle East & Africa
    • 12.6.1 Saudi Arabia
    • 12.6.2 UAE
    • 12.6.3 Qatar
    • 12.6.4 South Africa
    • 12.6.5 Rest of Middle East & Africa

13 Key Developments

  • 13.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 13.2 Acquisitions & Mergers
  • 13.3 New Product Launch
  • 13.4 Expansions
  • 13.5 Other Key Strategies

14 Company Profiling

  • 14.1 Getinge AB
  • 14.2 Fedegari Autoclavi S.p.A
  • 14.3 Azbil Corporation
  • 14.4 Schematic Engineering Industries
  • 14.5 Germfree Laboratories, Inc.
  • 14.6 Chiyoda Corporation
  • 14.7 Hosokawa Micron B.V
  • 14.8 Bioquell Inc.
  • 14.9 NuAire Inc
  • 14.10 Hecht Technologie Gmbh
  • 14.11 Comecer S.P.A
  • 14.12 Skan AG
  • 14.13 M. Braun Inertgas-Systeme Gmbh
  • 14.14 Tema Sinergie S.P.A
  • 14.15 Chamunda Pharma Machinery Pvt. Ltd
  • 14.16 Isotech Design

List of Tables

  • Table 1 Global Pharmaceutical Isolator Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Pharmaceutical Isolator Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global Pharmaceutical Isolator Market Outlook, By Aseptic Isolators (2021-2030) ($MN)
  • Table 4 Global Pharmaceutical Isolator Market Outlook, By Containment Isolators (2021-2030) ($MN)
  • Table 5 Global Pharmaceutical Isolator Market Outlook, By Bio Isolators (2021-2030) ($MN)
  • Table 6 Global Pharmaceutical Isolator Market Outlook, By Sampling And Weighing Isolators (2021-2030) ($MN)
  • Table 7 Global Pharmaceutical Isolator Market Outlook, By Active Pharmaceutical Ingredient (API) Manufacturing Isolators (2021-2030) ($MN)
  • Table 8 Global Pharmaceutical Isolator Market Outlook, By Radiopharmaceutical Isolators (2021-2030) ($MN)
  • Table 9 Global Pharmaceutical Isolator Market Outlook, By Fluid Dispensing Isolators (2021-2030) ($MN)
  • Table 10 Global Pharmaceutical Isolator Market Outlook, By Production Isolators (2021-2030) ($MN)
  • Table 11 Global Pharmaceutical Isolator Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 12 Global Pharmaceutical Isolator Market Outlook, By System Type (2021-2030) ($MN)
  • Table 13 Global Pharmaceutical Isolator Market Outlook, By Closed System (2021-2030) ($MN)
  • Table 14 Global Pharmaceutical Isolator Market Outlook, By Open System (2021-2030) ($MN)
  • Table 15 Global Pharmaceutical Isolator Market Outlook, By Pressure (2021-2030) ($MN)
  • Table 16 Global Pharmaceutical Isolator Market Outlook, By Positive Pressure (2021-2030) ($MN)
  • Table 17 Global Pharmaceutical Isolator Market Outlook, By Negative Pressure (2021-2030) ($MN)
  • Table 18 Global Pharmaceutical Isolator Market Outlook, By Configuration (2021-2030) ($MN)
  • Table 19 Global Pharmaceutical Isolator Market Outlook, By Floor Standing (2021-2030) ($MN)
  • Table 20 Global Pharmaceutical Isolator Market Outlook, By Modular (2021-2030) ($MN)
  • Table 21 Global Pharmaceutical Isolator Market Outlook, By Mobile (2021-2030) ($MN)
  • Table 22 Global Pharmaceutical Isolator Market Outlook, By Compact (2021-2030) ($MN)
  • Table 23 Global Pharmaceutical Isolator Market Outlook, By Table Top (2021-2030) ($MN)
  • Table 24 Global Pharmaceutical Isolator Market Outlook, By Portable (2021-2030) ($MN)
  • Table 25 Global Pharmaceutical Isolator Market Outlook, By Other Configuartions (2021-2030) ($MN)
  • Table 26 Global Pharmaceutical Isolator Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 27 Global Pharmaceutical Isolator Market Outlook, By Direct Tender (2021-2030) ($MN)
  • Table 28 Global Pharmaceutical Isolator Market Outlook, By Retail Sales (2021-2030) ($MN)
  • Table 29 Global Pharmaceutical Isolator Market Outlook, By Third Party Distributors (2021-2030) ($MN)
  • Table 30 Global Pharmaceutical Isolator Market Outlook, By Application (2021-2030) ($MN)
  • Table 31 Global Pharmaceutical Isolator Market Outlook, By Sterility Testing (2021-2030) ($MN)
  • Table 32 Global Pharmaceutical Isolator Market Outlook, By Sampling/ Weighing/ Distribution (2021-2030) ($MN)
  • Table 33 Global Pharmaceutical Isolator Market Outlook, By Medical Device Manufacturing (2021-2030) ($MN)
  • Table 34 Global Pharmaceutical Isolator Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 35 Global Pharmaceutical Isolator Market Outlook, By End User (2021-2030) ($MN)
  • Table 36 Global Pharmaceutical Isolator Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 37 Global Pharmaceutical Isolator Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
  • Table 38 Global Pharmaceutical Isolator Market Outlook, By Academic and Research Institutes (2021-2030) ($MN)
  • Table 39 Global Pharmaceutical Isolator Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
  • Table 40 Global Pharmaceutical Isolator Market Outlook, By Contract Research Organizations (2021-2030) ($MN)
  • Table 41 Global Pharmaceutical Isolator Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.